"Chris plays an essential role in identifying the strategic intersection between patient and corporate interests. He brings people together around a common goal and gets things done with ease, grace, speed and results."

Wanda S. Hamilton Executive Director AMD Alliance International

“Chris provided wise and practical counsel at a critical time. He helped us communicate effectively with our stakeholders and apply lessons learned from other companies.”

William A. Hockett EVP, Corporate Communications Myriad Genetics

"Chris understands what’s at stake for clients and agencies in today’s competitive healthcare environment. His energy, perspective and quest for perfection can help raise the bar on delivery."

Gil Bashe Executive Vice President Health Practice Leader Makovsky + Company

"SmithSolve offers more than public relations advice. Chris understands our business strategy and functions as part of our team. He helps us make sure that colleagues worldwide speak with one voice and a common goal in mind."

Director Worldwide Commercial Development Pharmaceutical Company

"My experience is that Chris delivers more than just crisp, professional execution. What he brings to the table is a true understanding of communication strategy. He creates a coherent, cohesive plan resulting in a sustainable program that drives perception and changes behavior."

Paul Chaney Chairman, EyeGate Pharmaceuticals

"SmithSolve helped us design a highly targeted disease education campaign that directly reached patients in need."

Senior Product Manager Pharmaceutical Company

"Chris brings a rare combination of strategic and tactical skills. Our management team relies on him to develop simple, clear messages that help drive our business forward."

David Hallal Senior Vice President Commercial Operations, Americas Alexion Pharmaceuticals

"When new competition threatened our product, Chris made sure that we communicated proactively with investors, opinion leaders, media, advocates and employees. He delivered under pressure and increased awareness of our science and pipeline."

David Guyer, MD Partner, SV Life Sciences Former CEO and Co-Founder Eyetech Pharmaceuticals